Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Excitatory amino acid transporters (EAATs) limit glutamatergic signaling and maintain extracellular glutamate concentrations below neurotoxic levels. Of the five known EAAT isoforms (EAATs 1-5), only the neuronal isoform, EAAT3 (EAAC1), can efficiently transport the uncharged amino acid L-cysteine. EAAT3-mediated cysteine transport has been proposed to be a primary mechanism used by neurons to obtain cysteine for the synthesis of glutathione, a key molecule in preventing oxidative stress and neuronal toxicity. The molecular mechanisms underlying the selective transport of cysteine by EAAT3 have not been elucidated. Here we propose that the transport of cysteine through EAAT3 requires formation of the thiolate form of cysteine in the binding site. Using Xenopus oocytes and HEK293 cells expressing EAAT2 and EAAT3, we assessed the transport kinetics of different substrates and measured transporter-associated currents electrophysiologically. Our results show that L-selenocysteine, a cysteine analog that forms a negatively-charged selenolate ion at physiological pH, is efficiently transported by EAATs 1-3 and has a much higher apparent affinity for transport when compared to cysteine. Using a membrane tethered GFP variant to monitor intracellular pH changes associated with transport activity, we observed that transport of either L-glutamate or L-selenocysteine by EAAT3 decreased intracellular pH, whereas transport of cysteine resulted in cytoplasmic alkalinization. No change in pH was observed when cysteine was applied to cells expressing EAAT2, which displays negligible transport of cysteine. Under conditions that favor release of intracellular substrates through EAAT3 we observed release of labeled intracellular glutamate but did not detect cysteine release. Our results support a model whereby cysteine transport through EAAT3 is facilitated through cysteine de-protonation and that once inside, the thiolate is rapidly re-protonated. Moreover, these findings suggest that cysteine transport is predominantly unidirectional and that reverse transport does not contribute to depletion of intracellular cysteine pools.
???displayArticle.pubmedLink???
25275463
???displayArticle.pmcLink???PMC4183567 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 2. Selenocysteine is transported by EAATs 1â3.A) Representative recordings (upper panel) and averaged normalized transport currents (lower panel) measured at â60 mV as a function of the L-selenocysteine concentration in EAAT3 expressing oocytes (nâ=â6). Data are presented as the mean and Std. dev. of the mean and fit with the Hill equation to estimate the Km for transport. B) Comparison of the maximal transport currents at â60 mV for L-selenocysteine and L-cysteine by EAAT1 (n>3), EAAT2 (n>5) or EAAT3 (n>10) normalized to the maximal currents induced by L-glutamate measured in the same oocyte. C) Comparison of averaged current-voltage relationships recorded from oocytes expressing EAAT3 for both 1 mM glutamate (red symbols, nâ=â4) and 1 mM selenocysteine (blue symbols, nâ=â4). Black symbols indicate the averaged current voltage relationship of the same cells in the absence of substrate (nâ=â4) and the solid line represents the average of water injected oocytes in the presence of 1 mM glutamate (nâ=â5).
Figure 3. Inhibition of glutamate transport by L-Selenocysteine and L-Cysteine for EAAT 2 and EAAT 3.Inhibition of radiolabeled glutamate uptake using varying concentrations of L-cysteine (circles) or L-selenocysteine (triangles) in HEK293 cells expressing EAAT2 (A, n>5 for each data point) or EAAT3 (B, n>5 for each data point). Data are represented as the mean and the standard error of the mean with non-linear curve fit to calculate the IC50s.
Figure 4. pH affects glutamate inhibition of cysteine transport.Glutamate inhibition of cysteine uptake from oocytes expressing EAAT3 at three different cysteine concentrations: 30 µM (circles), 300 µM (triangles) and 1 mM (squares) at pH 6.9 (A) and pH 8.5 (B).
Figure 5. mEGFPpH detects intracellular pH changes induced by glutamate transport.Representative image of mEGFPpH transfected HEK293 cells (A) and representative fluorescence traces from HEK293 cells expressing mEGFPpH perfused with 50 mM NH4Cl (B). Y axis indicates the ratio of fluorescence emission at 510 nm from excitation at 485 nm and 405 nm (F485/F405) (B). Arrows in A indicate the cells from which the traces in B were recorded. C) Fluorescence ratio (F485/F405) as a function of induced intracellular pH following NH4Cl perfusion (B). D) Perfusion of increasing concentrations of L-glutamate results in increased rate of mEGFPpH fluorescence decrease in HEK293 cells co-transfected with EAAT3 and mEGFPpH. The Y-axis units are the fluorescence ratio for emission at 510 nm with excitation at 485 and 405 nm (F485/F405). E) Perfusion with 100 µM D-aspartate results in intracellular acidification with slope magnitude similar to that for 100 µM L-glutamate (bar graph). Y-axis units are the fluorescence ratio for emission at 510 nm with excitation at 485 and 405 nm (F485/F405). F) Representation of the magnitude of the slope of mEGFPpH fluorescence ratio decrease (left y-axis) as a function of the applied glutamate concentration compared with the glutamate transport activity (right y-axis) in similarly transfected cells.
Figure 6. Transport of substrates in cells expressing EAAT2 or EAAT3 differentially affects intracellular pH.Representative fluorescence recordings from HEK293 cells expressing EAAT2 (A) or EAAT3 (B) in response to short applications of different concentrations of L-cysteine, L-glutamate or L-selenocysteine. The magnitude of maximal steady state slopes (A and B) are plotted in bar graphs below each trace, normalized to the glutamate slope magnitude. C) Representative trace of the effect on cysteine induced mEGFPpH fluorescence changes in EAAT3 expressing HEK293 cells with (left) or without (right) 100 µM TBOA. The Y-axis units for traces represent the fluorescence ratio for emission at 510 nm with excitation at 485 and 405 nm (F485/F405).
Figure 7. EAAT3 dependent release of [3H]-L-glutamate or [35S]-L-cysteine.A and B) Release of [35S]-L-Cysteine (A) or [3H]-L-Glutamate (B) from oocytes co-expressing EAAT3 and ASCT, in response to different buffers and conditions C) Averaged current-voltage relationships recorded from oocytes expressing EAAT3 alone (nâ=â6) or co-expressed with ASCT1 (nâ=â4) in response to a family of voltage pulses in the absence (black symbols) and the presence of 1 mM serine (blue symbols) or 1 mM glutamate (red symbols). The solid line represents un-injected oocytes in the presence of 1 mM glutamate and 1 mM serine (nâ=â3).
Amara,
Excitatory amino acid transporters: keeping up with glutamate.
2002, Pubmed
Amara,
Excitatory amino acid transporters: keeping up with glutamate.
2002,
Pubmed
Aoyama,
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.
2006,
Pubmed
Aoyama,
Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1).
2013,
Pubmed
Arriza,
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex.
1994,
Pubmed
,
Xenbase
Arriza,
Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family.
1993,
Pubmed
,
Xenbase
Bendahan,
Arginine 447 plays a pivotal role in substrate interactions in a neuronal glutamate transporter.
2000,
Pubmed
,
Xenbase
Berman,
N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.
2011,
Pubmed
Billups,
Anion conductance behavior of the glutamate uptake carrier in salamander retinal glial cells.
1996,
Pubmed
Chen,
The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures.
2003,
Pubmed
Danbolt,
Glutamate uptake.
2001,
Pubmed
Elsliger,
Structural and spectral response of green fluorescent protein variants to changes in pH.
1999,
Pubmed
Erecińska,
Amino acid neurotransmitters in the CNS. Characteristics of the acidic amino acid exchange.
1986,
Pubmed
Galietta,
Novel CFTR chloride channel activators identified by screening of combinatorial libraries based on flavone and benzoquinolizinium lead compounds.
2001,
Pubmed
Grewer,
Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia.
2008,
Pubmed
Hawkes,
Regulation of redox signaling by selenoproteins.
2010,
Pubmed
Kanai,
Electrogenic properties of the epithelial and neuronal high affinity glutamate transporter.
1995,
Pubmed
,
Xenbase
Koch,
Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.
1999,
Pubmed
,
Xenbase
Kozak,
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
1987,
Pubmed
Kryukov,
Characterization of mammalian selenoproteomes.
2003,
Pubmed
Lacourciere,
Utilization of selenocysteine as a source of selenium for selenophosphate biosynthesis.
2001,
Pubmed
Levi,
Carrier-mediated release of neurotransmitters.
1993,
Pubmed
Levy,
Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake.
1998,
Pubmed
Lobanov,
Eukaryotic selenoproteins and selenoproteomes.
2009,
Pubmed
Nothmann,
Hetero-oligomerization of neuronal glutamate transporters.
2011,
Pubmed
,
Xenbase
Poitry-Yamate,
Neuronal-induced and glutamate-dependent activation of glial glutamate transporter function.
2002,
Pubmed
Renner,
Na+-H+ exchange activity in rat hepatocytes: role in regulation of intracellular pH.
1989,
Pubmed
Scopelliti,
Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members.
2013,
Pubmed
,
Xenbase
Seal,
Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductance.
2001,
Pubmed
Seal,
Excitatory amino acid transporters: a family in flux.
1999,
Pubmed
Skene,
Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43.
1989,
Pubmed
Stadtman,
Selenocysteine.
1996,
Pubmed
Torres-Salazar,
Neuronal glutamate transporters vary in substrate transport rate but not in unitary anion channel conductance.
2007,
Pubmed
,
Xenbase
Utsunomiya-Tate,
Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter.
1996,
Pubmed
,
Xenbase
Wadiche,
Ion fluxes associated with excitatory amino acid transport.
1995,
Pubmed
,
Xenbase
Watts,
A sensitive membrane-targeted biosensor for monitoring changes in intracellular chloride in neuronal processes.
2012,
Pubmed
Watzke,
On the mechanism of proton transport by the neuronal excitatory amino acid carrier 1.
2000,
Pubmed
Zerangue,
Interaction of L-cysteine with a human excitatory amino acid transporter.
1996,
Pubmed
,
Xenbase
Zerangue,
Flux coupling in a neuronal glutamate transporter.
1996,
Pubmed
,
Xenbase
Zerangue,
ASCT-1 is a neutral amino acid exchanger with chloride channel activity.
1996,
Pubmed
,
Xenbase
Zhang,
Transport direction determines the kinetics of substrate transport by the glutamate transporter EAAC1.
2007,
Pubmed